Design, synthesis and biological evaluation of thiazolidinone derivatives as potential EGFR and HER-2 kinase inhibitors
- PMID: 19914835
- DOI: 10.1016/j.bmc.2009.10.051
Design, synthesis and biological evaluation of thiazolidinone derivatives as potential EGFR and HER-2 kinase inhibitors
Abstract
Two series of thiazolidinone derivatives designing for potential EGFR and HER-2 kinase inhibitors have been discovered. Some of them exhibited significant EGFR and HER-2 inhibitory activity. Compound 2-(2-(5-bromo-2-hydroxybenzylidene)hydrazinyl)thiazol-4(5H)-one (12) displayed the most potent inhibitory activity (IC(50)=0.09 microM for EGFR and IC(50)=0.42 microM for HER-2), comparable to the positive control erlotinib. Docking simulation was performed to position compound 12 into the EGFR active site to determine the probable binding model. Antiproliferative assay results indicating that some of the thiazolidinone derivatives own high antiproliferative activity against MCF-7. Compound 12 with potent inhibitory activity in tumor growth inhibition would be a potential anticancer agent.
Copyright (c) 2009 Elsevier Ltd. All rights reserved.
Similar articles
-
Synthesis and structure-activity relationships of N-benzyl-N-(X-2-hydroxybenzyl)-N'-phenylureas and thioureas as antitumor agents.Bioorg Med Chem. 2010 Jan 1;18(1):305-13. doi: 10.1016/j.bmc.2009.10.054. Epub 2009 Oct 31. Bioorg Med Chem. 2010. PMID: 19914837
-
Synthesis, biological evaluation and molecular docking studies of amide-coupled benzoic nitrogen mustard derivatives as potential antitumor agents.Bioorg Med Chem. 2010 Jan 15;18(2):880-6. doi: 10.1016/j.bmc.2009.11.037. Epub 2009 Nov 22. Bioorg Med Chem. 2010. PMID: 20005116
-
Design, synthesis and biological evaluation of pyrazolyl-thiazolinone derivatives as potential EGFR and HER-2 kinase inhibitors.Bioorg Med Chem. 2012 Mar 15;20(6):2010-8. doi: 10.1016/j.bmc.2012.01.051. Epub 2012 Feb 4. Bioorg Med Chem. 2012. PMID: 22361272
-
The development of HKI-272 and related compounds for the treatment of cancer.Arch Pharm (Weinheim). 2008 Aug;341(8):465-77. doi: 10.1002/ardp.200800009. Arch Pharm (Weinheim). 2008. PMID: 18493974 Review.
-
Design, synthesis and biological evaluation of 2-amino-4-(1,2,4-triazol)pyridine derivatives as potent EGFR inhibitors to overcome TKI-resistance.Eur J Med Chem. 2020 Feb 1;187:111966. doi: 10.1016/j.ejmech.2019.111966. Epub 2019 Dec 14. Eur J Med Chem. 2020. PMID: 31869655 Review.
Cited by
-
Identifying HER2 inhibitors from natural products database.PLoS One. 2011;6(12):e28793. doi: 10.1371/journal.pone.0028793. Epub 2011 Dec 12. PLoS One. 2011. PMID: 22174899 Free PMC article.
-
Synthesis and Antiproliferative Potential of Thiazole and 4-Thiazolidinone Containing Motifs as Dual Inhibitors of EGFR and BRAFV600E.Molecules. 2023 Dec 5;28(24):7951. doi: 10.3390/molecules28247951. Molecules. 2023. PMID: 38138441 Free PMC article.
-
Microwave-assisted synthesis of some hybrid molecules containing penicillanic acid or cephalosporanic acid moieties and investigation of their biological activities.Med Chem Res. 2014;23(6):3128-3143. doi: 10.1007/s00044-013-0898-4. Epub 2013 Dec 29. Med Chem Res. 2014. PMID: 24719549 Free PMC article.
-
3-{2-[2-(3-Hy-droxy-benzyl-idene)hydrazin-1-yl]-1,3-thia-zol-4-yl}-2H-chromen-2-one hemihydrate.Acta Crystallogr Sect E Struct Rep Online. 2010 May 29;66(Pt 6):o1498-9. doi: 10.1107/S1600536810019653. Acta Crystallogr Sect E Struct Rep Online. 2010. PMID: 21579559 Free PMC article.
-
Recent advances in synthetic strategies and SAR of thiazolidin-4-one containing molecules in cancer therapeutics.Cancer Metastasis Rev. 2023 Sep;42(3):847-889. doi: 10.1007/s10555-023-10106-1. Epub 2023 May 19. Cancer Metastasis Rev. 2023. PMID: 37204562 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Chemical Information
Research Materials
Miscellaneous